Patients with type 2 diabetes (T2D) frequently have increased cardiovascular (CV) risk, yet real-world control of guideline-recommended cardiometabolic risk factors remains suboptimal. We quantified the proportion of Romanian adults with T2D who were at recommended targets for key CV risk factors across ESC CV risk categories. In this single-center cross-sectional study, we recorded HbA1c, LDL-cholesterol (LDL-c), triglycerides and blood pressure (BP). Targets were defined using contemporary guideline recommendations (HbA1c <7.0%, BP <130/80 mmHg, triglycerides <150 mg/dL, and risk-category-specific LDL-c targets). BMI was reported descriptively and was not considered treatment target. We included 174 patients (median age 61 years; 50% women); 81.6% were at very high and 14.4% at high CV risk. Overall, 46.6% were at the HbA1c target, 20.1% at the LDL-c target, 58.0% at the triglyceride target, and 42.0% at the BP target. Across ESC risk categories, control of individual targets was consistently limited, with particularly low proportions at LDL-c target. In this real-world Romanian T2D cohort, a minority of patients were at recommended targets for major CV risk factors, especially LDL-c, underscoring the need for systematic, risk-based intensification of cardiometabolic management.
Luca et al. (Tue,) studied this question.